<!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" class="fa-events-icons-ready gr__clinicaltrials_gov" lang="en">


<div id="main-content">

<div class="indent2">
        	<h1 class="solo_record">Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis (PETAL)</h1>

  <div class="row">
    <div class="column left">
      <div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
        <table>
          <tbody><tr>
            <td style="width:5%">
              <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/warning.png" style="width:1.3em;" alt="">
            </td>
            <td>
              The safety and scientific validity of this study is the 
responsibility of the study sponsor and investigators. Listing a study 
does not mean it has been evaluated by the U.S. Federal Government.
                            Read our <a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
          </tr>
        </tbody></table>
      </div>      </div> 
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT00437658</div>
-->
    <div class="column right">
  <table style="width:90%">
  <tbody><tr><td>ClinicalTrials.gov Identifier: NCT00437658</td>
  </tr>
  <tr><td>
      
       
              <div class="not-recruiting-status">
                        <span style="display:inline;" class="term" data-term="recruitment status" title="Show definition" tabindex="0">Recruitment Status <i class="fa fa-info-circle term" aria-hidden="true" data-term="recruitment status" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: 
                    Completed
                  
                
  <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="first posted" title="Show definition" tabindex="0">First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: February 21, 2007</div>
      <div style="font-size:inherit">
    <span style="display:inline;" class="term" data-term="results first posted" title="Show definition" tabindex="0">Results First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="results first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: October 12, 2018</div>
    <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="last update posted" title="Show definition" tabindex="0">Last Update Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="last update posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: October 12, 2018</div>

  
      </div>
  </td>
  </tr>
  </tbody></table>
  </div>
  </div>


                <div class="info-title">Sponsor:</div>
                <div class="info-text" id="sponsor"> AbbVie </div>

                              <div class="info-title">Information provided by (Responsible Party):</div>
                <div class="info-text" id="responsibleparty">AbbVie</div>
              	</div>
<br>


<div id="tabs">
    <ul id="tab-links">
		<li id="full-text"><a href="https://clinicaltrials.gov/ct2/show/study/NCT00437658?sect=X01256">Study Details</a></li>
		<li id="tabular"><a href="https://clinicaltrials.gov/ct2/show/record/NCT00437658?sect=X01256">Tabular View</a></li>
  					<li id="results" class="current"> Study Results</li>
				<li id="disclaimer"><a title="Disclaimer - opens new window" href="https://clinicaltrials.gov/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false">Disclaimer</a></li>
		<li id="howtoread"><a title="How to Read a Study Record - opens new window" href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false">How to Read a Study Record</a></li>
    </ul>
</div>  <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->

  <div id="tab-body">
  <div class="indent2" style="background-color:white;">
  <!-- Title section -->
  <div class="indent3" style="text-align:center;">
    
  
  <table class="data_table" style="margin:3ex 0;" width="80%" cellspacing="0" cellpadding="5" border="1">

        <tbody><tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Type: </th>
      <td class="body3" style="text-align:left;">Interventional</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Design: </th>
      <td class="body3" style="text-align:left;">Allocation:&nbsp;Randomized;
 &nbsp; Intervention&nbsp;Model:&nbsp;Parallel&nbsp;Assignment; &nbsp; 
Masking:&nbsp;Quadruple&nbsp;(Participant,&nbsp;Care&nbsp;Provider,&nbsp;Investigator,&nbsp;Outcomes&nbsp;Assessor);
 &nbsp; Primary&nbsp;Purpose:&nbsp;Treatment</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
         Condition:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Endometriosis<br>
              </td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
        Interventions:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Drug: Elagolix<br>
                Drug: Subcutaneous depot medroxyprogesterone acetate (DMPA-SC)<br>
                Drug: Placebo to Elagolix<br>
                Drug: Placebo to DMPA-SC<br>
              </td>
    </tr>
    
  </tbody></table>

  
  </div>
  
<!-- participant flow section -->
<div class="indent1">

  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Participant Flow</span>

  <a name="part" id="part"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">      
      <a title="Hide participant flow" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X1256#part">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Participant Flow
      </a>
    </div>

    <br>
    <span class="header3">Recruitment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Key information relevant to the recruitment process for the
          overall study, such as dates of the recruitment period and locations
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      Participants were randomized at 58 centers in the United States.
                  </td>
      </tr>
    </tbody></table>

    <br>
    <span class="header3">Pre-Assignment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Significant events and approaches for the overall study
          following participant enrollment, but prior to group assignment
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      This study consisted of a 24-week treatment period
 and a 24-week post-treatment period. Participants were randomized in a 
1:1:1 ratio to one of three treatment groups.
                  </td>
      </tr>
    </tbody></table>

    
    <br>
        
      
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_participant_color">&nbsp;</th>
      <th class="header3 bold_participant_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>

      <br>
              <span class="header3">Participant Flow for 2 periods<br><br></span>
      
                    
        <span class="header3">Period 1: &nbsp; Treatment Period (24 Weeks)</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg QD
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 75 mg BID
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                DMPA-SC
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  Received Study Drug&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;84&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;56&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;62&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;51&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;28&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;22&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;33&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Adverse Event&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 14&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Non-compliance&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 9&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lack of Efficacy&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Sponsor/Investigator Decision&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                <br>
        
                    
        <span class="header3">Period 2: &nbsp; Post-treatment Period (24 Weeks)</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg QD
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 75 mg BID
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                DMPA-SC
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;56&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;62&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;51&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;32&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;54&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;37&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;24&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;8&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;14&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Adverse Event&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Non-compliance&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 12&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 6&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 8&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lack of Efficacy&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Sponsor/Investigator Decision&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                <br>
        
              </div>
</div>
  
<!-- baseline section -->
<br>
<div class="indent1">

  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Baseline Characteristics</span>

  <a name="base" id="base"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide baseline characteristics" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X0256#base">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Baseline Characteristics
      </a>
    </div>

    <br>
    <span class="header3">Population Description</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_baseline_color" style="text-align:left;">
          Explanation of how the number of participants for analysis was determined.
          Includes whether analysis was per protocol, intention to treat, or another method.
          Also provides relevant details such as imputation technique, as appropriate.
        </th>
      </tr>
      <tr>
        <td class="body3 pale_baseline_color" style="vertical-align:top;">
                      No text entered.
                  </td>
      </tr>
    </tbody></table>

    <br>
    
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_baseline_color">&nbsp;</th>
      <th class="header3 bold_baseline_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Total</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Total of all reporting groups
                      </td>
        </tr>
      </tbody></table>
      
      <br>
            
          
          
    
      <span class="header3">Baseline Measures</span>
      <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
        <tbody><tr>
          <th class="brt bold_baseline_color" style="max-width:50%">&nbsp;</th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 150 mg QD&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 75 mg BID&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;DMPA-SC&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Total&nbsp;
            </th>
                  </tr>
    
            
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Overall Participants Analyzed&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br></span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;84&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;84&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;84&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;252&nbsp;                                  </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Age&nbsp;                <br><span class="body3">[Units:&nbsp;Years]<br>Mean (Standard Deviation)</span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;32.4&nbsp;&nbsp;(7.5)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.4&nbsp;&nbsp;(6.1)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;30.9&nbsp;&nbsp;(6.3)&nbsp;                                       
               </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.6&nbsp;&nbsp;(6.7)&nbsp;                                       
               </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Sex: Female, Male&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>               </th>
                                                <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                          </tr>
                          <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Female&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 84<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 84<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 84<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 252<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Male&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Race/Ethnicity, Customized&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>               </th>
                                                <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                          </tr>
                          <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Asian&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   1.2%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   1.2%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 2<span class="body3">   0.8%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Black&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 6<span class="body3">   7.1%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 10<span class="body3">  11.9%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 10<span class="body3">  11.9%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 26<span class="body3">  10.3%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  White&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 68<span class="body3">  81.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 70<span class="body3">  83.3%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 65<span class="body3">  77.4%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 203<span class="body3">  80.6%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Hispanic&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 8<span class="body3">   9.5%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 4<span class="body3">   4.8%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 6<span class="body3">   7.1%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 18<span class="body3">   7.1%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  American Indian or Alaska Native, Caucasian&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   1.2%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   0.4%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Black, Caucasian&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   1.2%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   0.4%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Caucasian, Hispanic&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   1.2%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 1<span class="body3">   0.4%</span>&nbsp;                                          </td>
                                                </tr>
                                        
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                    </tbody></table>
      
      
      
        </div>
</div>
  
<!-- outcome measures section -->
<br>
<div class="indent1">

  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Outcome Measures</span>
  <a name="all" id="all"></a>
  <div class="header3 indent2">

            <div style="margin-top:1.0ex;">
      <a title="Hide all outcome measures" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X0156#all">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide All Outcome Measures
      </a>
    </div>
    
                  <a name="outcome1" id="outcome1"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">1.&nbsp; Primary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24 &nbsp; [ Time Frame: Baseline and week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Primary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) was
 measured by dual X-ray absorptiometry (DXA). The percent change from 
baseline in spine and femur BMD at week 24 was assessed using a one-way 
analysis of variance (ANOVA) model. The absence of significant bone loss
 was supported if the lower bounds of the confidence intervals for the 
mean percent change in BMD were ≥ -2.2% for both the spine and femur at 
week 24.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Participants who received at 
least one dose (i.e., one tablet or injection) of study drug (safety 
analysis set) with available BMD data at both time points
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;55&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;62&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;50&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Spine at Week 24&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Least Squares Mean (95% Confidence Interval)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-0.11&nbsp;<br>
                                &nbsp;(-0.70&nbsp;to&nbsp;0.48)&nbsp;
                                                                                    </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-1.29&nbsp;<br>
                                &nbsp;(-1.85&nbsp;to&nbsp;-0.74)&nbsp;
                                                                                    </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-0.99&nbsp;<br>
                                &nbsp;(-1.61&nbsp;to&nbsp;-0.37)&nbsp;
                                                                                    </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Spine at Week 24</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome2" id="outcome2"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">2.&nbsp; Primary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24 &nbsp; [ Time Frame: Baseline and week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Primary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) was
 measured by dual X-ray absorptiometry (DXA). The percent change from 
baseline in spine and femur BMD at week 24 was assessed using a one-way 
analysis of variance (ANOVA) model. The absence of significant bone loss
 was supported if the lower bounds of the confidence intervals for the 
mean percent change in BMD were ≥ -2.2% for both the spine and femur at 
week 24.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Participants who received at 
least one dose (i.e., one tablet or injection) of study drug (safety 
analysis set) with available BMD data at both time points
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;56&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;64&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Femur at Week 24&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Least Squares Mean (95% Confidence Interval)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-0.47&nbsp;<br>
                                &nbsp;(-0.96&nbsp;to&nbsp;0.02)&nbsp;
                                                                                    </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-1.02&nbsp;<br>
                                &nbsp;(-1.48&nbsp;to&nbsp;-0.56)&nbsp;
                                                                                    </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                                          &nbsp;-1.29&nbsp;<br>
                                &nbsp;(-1.80&nbsp;to&nbsp;-0.77)&nbsp;
                                                                                    </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Femur at Week 24</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome3" id="outcome3"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">3.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of 
the Spine at Weeks 12 and 48 &nbsp; [ Time Frame: Baseline and weeks 12 
and 48 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Spine at Weeks 12 and 48</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) was
 measured by dual X-ray absorptiometry (DXA). The percent change from 
baseline in BMD was assessed using a one-way analysis of variance 
(ANOVA) model.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 12 and 48 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Participants who received at 
least one dose (i.e., one tablet or injection) of study drug (safety 
analysis set) with available BMD data at each time point
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Spine at Weeks 12 and 48&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Least Squares Mean (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.39&nbsp;<br>
                                      &nbsp;(-0.80&nbsp;to&nbsp;0.02)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-1.05&nbsp;<br>
                                      &nbsp;(-1.46&nbsp;to&nbsp;-0.64)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.57&nbsp;<br>
                                      &nbsp;(-0.98&nbsp;to&nbsp;-0.15)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 48&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;34&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 48&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;0.20&nbsp;<br>
                                      &nbsp;(-0.57&nbsp;to&nbsp;0.96)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.49&nbsp;<br>
                                      &nbsp;(-1.09&nbsp;to&nbsp;0.10)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.56&nbsp;<br>
                                      &nbsp;(-1.27&nbsp;to&nbsp;0.15)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Spine at Weeks 12 and 48</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome4" id="outcome4"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">4.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline in Bone Mineral Density of 
the Femur at Weeks 12 and 48 &nbsp; [ Time Frame: Baseline and weeks 12 
and 48 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline in Bone Mineral Density of the Femur at Weeks 12 and 48</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Bone mineral density (BMD) was
 measured by dual X-ray absorptiometry (DXA). The percent change from 
baseline in BMD was assessed using a one-way analysis of variance 
(ANOVA) model.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 12 and 48 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Participants who received at 
least one dose (i.e., one tablet or injection) of study drug (safety 
analysis set) with available BMD data at each time point
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline in Bone Mineral 
Density of the Femur at Weeks 12 and 48&nbsp;                        <br><span class="body3">[Units:&nbsp;Percent&nbsp;change]<br>Least Squares Mean (95% Confidence Interval)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.63&nbsp;<br>
                                      &nbsp;(-1.02&nbsp;to&nbsp;-0.24)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.54&nbsp;<br>
                                      &nbsp;(-0.92&nbsp;to&nbsp;-0.17)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.77&nbsp;<br>
                                      &nbsp;(-1.16&nbsp;to&nbsp;-0.39)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 48&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 48&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.38&nbsp;<br>
                                      &nbsp;(-1.10&nbsp;to&nbsp;0.33)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.86&nbsp;<br>
                                      &nbsp;(-1.41&nbsp;to&nbsp;-0.32)&nbsp;
                                                                                                      </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                                                            &nbsp;-0.76&nbsp;<br>
                                      &nbsp;(-1.42&nbsp;to&nbsp;-0.10)&nbsp;
                                                                                                      </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percent Change From Baseline in Bone Mineral Density of the Femur at Weeks 12 and 48</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome5" id="outcome5"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">5.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in N-telopeptide at Weeks 12, 24 and 48 &nbsp; [ Time Frame: Baseline and weeks 12, 24 and 48 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in N-telopeptide at Weeks 12, 24 and 48</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Blood samples to determine 
N-telopeptide concentrations were analyzed by a central laboratory using
 an enzyme-linked immunosorbent assay (ELISA). Change from baseline in 
N-telopeptide was analyzed using a one-way ANOVA model.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 12, 24 and 48 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Participants who received at 
least one dose (i.e., one tablet or injection) of study drug (safety 
analysis set) with available BMD data at each time point
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in N-telopeptide at Weeks 12, 24 and 48&nbsp;                        <br><span class="body3">[Units:&nbsp;nM&nbsp;bone&nbsp;collagen&nbsp;equivalents&nbsp;(BCE)]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;0.94&nbsp;&nbsp;(0.43)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;0.57&nbsp;&nbsp;(0.43)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;0.74&nbsp;&nbsp;(0.45)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;49&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;0.23&nbsp;&nbsp;(0.50)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.30&nbsp;&nbsp;(0.48)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.24&nbsp;&nbsp;(0.54)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 48&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;36&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 48&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.28&nbsp;&nbsp;(0.61)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.53&nbsp;&nbsp;(0.48)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.39&nbsp;&nbsp;(0.58)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in N-telopeptide at Weeks 12, 24 and 48</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome6" id="outcome6"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">6.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a Response in the 
Dysmenorrhea Component of the Composite Pelvic Signs and Symptoms Score 
(CPSSS) at Week 24 &nbsp; [ Time Frame: Baseline and week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of 
Participants With a Response in the Dysmenorrhea Component of the 
Composite Pelvic Signs and Symptoms Score (CPSSS) at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea (pain during 
menstruation), dyspareunia (painful intercourse), non-menstrual pelvic 
pain, pelvic tenderness, and pelvic induration (hardening). Each 
component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 = 
moderate, and 3 = severe). The dysmenorrhea score was based on the 
participant's response to the question "Have you had painful 
menstruation during the last 28 days?”.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Participants were 
classified as responders for dysmenorrhea if they reported a 1 point or 
greater reduction (improvement) from baseline.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary visual 
analog scale (VAS) values or provided an assessment of either 
dysmenorrhea or non-menstrual pelvic pain at week 4 or later during the 
treatment phase (intent-to-treat) with available data.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;57&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;65&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a Response in 
the Dysmenorrhea Component of the Composite Pelvic Signs and Symptoms 
Score (CPSSS) at Week 24&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;86.0&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;73.8&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;86.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Percentage of Participants With a Response in the Dysmenorrhea Component
 of the Composite Pelvic Signs and Symptoms Score (CPSSS) at Week 24</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD vs. DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Non-Inferiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Pearson chi-squared</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.9630</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in response rates <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.3</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-13.4 to 12.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Statistical 
non-inferiority was defined when the lower bound of the 95% 2-sided 
confidence interval for the difference between an elagolix dose and 
DMPA-SC in the response rate was no less than -20% at week 24 for both 
dysmenorrhea and non-menstrual pelvic pain.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference in response rate = elogolix - DMPA-SC
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Percentage of Participants With a Response in the Dysmenorrhea Component
 of the Composite Pelvic Signs and Symptoms Score (CPSSS) at Week 24</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID vs. DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Non-Inferiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Pearson chi-squared</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.1010</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in response rates <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-12.4</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-26.7 to 1.8</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Statistical 
non-inferiority was defined when the lower bound of the 95% 2-sided 
confidence interval for the difference between an elagolix dose and 
DMPA-SC in the response rate was no less than -20% at week 24 for both 
dysmenorrhea and non-menstrual pelvic pain.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference in response rate = elogolix - DMPA-SC
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome7" id="outcome7"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">7.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a Response in the 
Non-menstrual Pelvic Pain Component of the CPSSS at Week 24 &nbsp; [ 
Time Frame: Baseline and week 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With a Response in the Non-menstrual Pelvic Pain Component of the CPSSS at Week 24</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The CPSSS consists of 5 
components that address dysmenorrhea, dyspareunia, non-menstrual pelvic 
pain, pelvic tenderness, and pelvic induration. Each component was 
scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 = moderate, and 3 =
 severe). The non-menstrual pelvic pain score was based on participant's
 response to the question “Have you had pelvic pain during the last 28 
days?” Participants were classified as responders for non-menstrual 
pelvic pain if they reported a 1 point or greater reduction 
(improvement) from baseline.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and week 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary visual 
analog scale (VAS) values or provided an assessment of either 
dysmenorrhea or non-menstrual pelvic pain at week 4 or later during the 
treatment phase (intent-to-treat) with available data.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;57&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;65&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;51&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a Response in 
the Non-menstrual Pelvic Pain Component of the CPSSS at Week 24&nbsp;   
                     <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;86.0&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;76.9&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;76.5&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Percentage of Participants With a Response in the Non-menstrual Pelvic 
Pain Component of the CPSSS at Week 24</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD vs. DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Non-Inferiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Pearson chi-squared</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.2048</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in response rates <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">9.5</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.2 to 24.2</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Statistical 
non-inferiority was defined when the lower bound of the 95% 2-sided 
confidence interval for the difference between an elagolix dose and 
DMPA-SC in the response rate was no less than -20% at week 24 for both 
dysmenorrhea and non-menstrual pelvic pain.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference in response rates = elagolix - DMPA-SC
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Percentage of Participants With a Response in the Non-menstrual Pelvic 
Pain Component of the CPSSS at Week 24</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID vs. DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Non-Inferiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Pearson chi-squared</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.9544</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in response rates <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.5</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-15.1 to 16.0</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Statistical 
non-inferiority was defined when the lower bound of the 95% 2-sided 
confidence interval for the difference between an elagolix dose and 
DMPA-SC in the response rate was no less than -20% at week 24 for both 
dysmenorrhea and non-menstrual pelvic pain.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          Difference in response rates = elagolix - DMPA-SC
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome8" id="outcome8"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">8.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a Response in the 
Dysmenorrhea Component of the CPSSS Over Time &nbsp; [ Time Frame: 
Baseline and weeks 4, 8, 12, 16, 20, 24, 28, 36, and 48 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With a Response in the Dysmenorrhea Component of the CPSSS Over Time</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe). The dysmenorrhea score was based on the 
participant's response to the question "Have you had painful 
menstruation during the last 28 days?".</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Participants were 
classified as responders for dysmenorrhea if they reported a 1 point or 
greater reduction (improvement) from baseline.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, 24, 28, 36, and 48 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a Response in 
the Dysmenorrhea Component of the CPSSS Over Time&nbsp;                 
       <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75.3&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;80.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74.7&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;84.0&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;84.0&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;79.5&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73.2&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.2&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.1&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;87.5&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.6&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;91.2&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76.5&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83.3&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;86.0&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73.8&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;86.3&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 28&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 28&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70.8&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57.4&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;93.3&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 36&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;41&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 36&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52.5&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44.6&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;80.5&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 48&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 48&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63.6&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58.2&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66.7&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Percentage of Participants With a Response in the 
Dysmenorrhea Component of the CPSSS Over Time</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome9" id="outcome9"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">9.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants With a Response in the 
Non-menstrual Pelvic Pain Component of the CPSSS Over Time &nbsp; [ Time
 Frame: Baseline and weeks 4, 8, 12, 16, 20, 24, 28, 36, and 48 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants With a Response in the Non-menstrual Pelvic Pain Component of the CPSSS Over Time</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The CPSSS consists of 5 
components that address dysmenorrhea, dyspareunia, non-menstrual pelvic 
pain, pelvic tenderness, and pelvic induration. Each component was 
scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 = moderate, and 3 =
 severe). The non-menstrual pelvic pain score was based on participant's
 response to the question "Have you had pelvic pain during the last 28 
days?" Participants were classified as responders for non-menstrual 
pelvic pain if they reported a 1 point or greater reduction 
(improvement) from baseline.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, 24, 28, 36, and 48 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants With a Response in 
the Non-menstrual Pelvic Pain Component of the CPSSS Over Time&nbsp;    
                    <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74.1&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56.6&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68.7&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76.0&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.2&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74.6&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.2&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71.6&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82.8&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;78.3&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70.2&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;80.9&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75.9&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;86.0&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76.9&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76.5&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 28&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 28&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73.3&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 36&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;40&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;41&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 36&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67.5&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68.3&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 48&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 48&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66.7&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56.4&nbsp;                                                        
          </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71.8&nbsp;                                                        
          </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Percentage of Participants With a Response in the 
Non-menstrual Pelvic Pain Component of the CPSSS Over Time</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome10" id="outcome10"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">10.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Total CPSSS During the Treatment
 Period &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24
 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Total CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Dysmenorrhea, 
dyspareunia, and nonmenstrual pelvic pain scores are based on the 
participant's assessment, pelvic tenderness and induration were assessed
 by the investigator based on findings associated with a pelvic 
examination.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The total CPSSS has a 
maximum possible value of 15 (total score range: 0 to 15, where a lower 
score indicates less signs and symptoms of endometriosis or better 
functioning).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Total CPSSS During the Treatment Period&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.9&nbsp;&nbsp;(0.29)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.7&nbsp;&nbsp;(0.29)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.8&nbsp;&nbsp;(0.29)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.9&nbsp;&nbsp;(0.30)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.8&nbsp;&nbsp;(0.30)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.5&nbsp;&nbsp;(0.30)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;72&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.6&nbsp;&nbsp;(0.31)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.1&nbsp;&nbsp;(0.30)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.2&nbsp;&nbsp;(0.31)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.5&nbsp;&nbsp;(0.32)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.4&nbsp;&nbsp;(0.31)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.6&nbsp;&nbsp;(0.33)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.1&nbsp;&nbsp;(0.33)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.3&nbsp;&nbsp;(0.31)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.8&nbsp;&nbsp;(0.34)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.5&nbsp;&nbsp;(0.34)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.2&nbsp;&nbsp;(0.32)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.3&nbsp;&nbsp;(0.36)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Total CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.5</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-6.2 to -4.8</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in total CPSSS at week 24. Change from 
baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Total CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.2</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.8 to -4.5</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in total CPSSS at week 24. Change from 
baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Total CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.3</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-6.0 to -4.6</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in total CPSSS at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome11" id="outcome11"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">11.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Total CPSSS Excluding 
Dyspareunia During the Treatment Period &nbsp; [ Time Frame: Baseline 
and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Total CPSSS Excluding Dyspareunia During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Dysmenorrhea, 
dyspareunia, and nonmenstrual pelvic pain scores are based on the 
participant's assessment, pelvic tenderness and induration were assessed
 by the investigator based on findings associated with a pelvic 
examination.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The total CPSSS 
excluding dyspareunia has a maximum possible value of 12 (total score 
range: 0 to 12, where a lower score indicates less signs and symptoms of
 endometriosis or better functioning).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Total CPSSS Excluding 
Dyspareunia During the Treatment Period&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.4&nbsp;&nbsp;(0.25)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.4&nbsp;&nbsp;(0.25)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.3&nbsp;&nbsp;(0.25)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.1&nbsp;&nbsp;(0.26)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.2&nbsp;&nbsp;(0.26)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.8&nbsp;&nbsp;(0.26)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;72&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.8&nbsp;&nbsp;(0.26)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.4&nbsp;&nbsp;(0.26)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.7&nbsp;&nbsp;(0.27)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.6&nbsp;&nbsp;(0.27)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.6&nbsp;&nbsp;(0.27)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-3.9&nbsp;&nbsp;(0.29)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.4&nbsp;&nbsp;(0.28)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.4&nbsp;&nbsp;(0.27)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.1&nbsp;&nbsp;(0.30)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.6&nbsp;&nbsp;(0.29)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.4&nbsp;&nbsp;(0.28)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-4.5&nbsp;&nbsp;(0.31)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Total CPSSS Excluding Dyspareunia During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt;0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.6</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.1 to -4.0</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in total CPSSS excluding dyspareunia at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Total CPSSS Excluding Dyspareunia During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt;0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.4</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.0 to -3.9</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in total CPSSS excluding dyspareunia at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Total CPSSS Excluding Dyspareunia During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.5</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.1 to -3.9</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in total CPSSS excluding dyspareunia at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome12" id="outcome12"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">12.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Dysmenorrhea Component of the 
CPSSS During the Treatment Period &nbsp; [ Time Frame: Baseline and 
weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Dysmenorrhea Component of the CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The dysmenorrhea score 
was based on the participant's response to the question "Have you had 
painful menstruation during the last 28 days?".</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Dysmenorrhea Component 
of the CPSSS During the Treatment Period&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.4&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.5&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.3&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.6&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.7&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.5&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.3&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.7&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.5&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.6&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.8&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.8&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.4&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.5&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.4&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.5&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.4&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.7&nbsp;&nbsp;(0.14)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Dysmenorrhea Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.5</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.7 to -1.2</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dysmenorrhea at week 24. Change from
 baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Dysmenorrhea Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.4</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.6 to -1.2</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dysmenorrhea at week 24. Change from
 baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Dysmenorrhea Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.7</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.9 to -1.4</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dysmenorrhea at week 24. Change from
 baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome13" id="outcome13"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">13.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Dyspareunia Component of the 
CPSSS During the Treatment Period &nbsp; [ Time Frame: Baseline and 
weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Dyspareunia Component of the CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The dyspareunia score 
was based on the participant's response to the question “Have you had 
painful intercourse during the last 28 days?” Change from baseline was 
analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Dyspareunia Component of
 the CPSSS During the Treatment Period&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;62&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;59&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.4&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.5&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;49&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.12)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.14)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;41&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.14)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.14)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;30&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.13)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.14)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.15)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Dyspareunia Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.2</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.4 to -0.9</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dyspareunia at week 24. Change from 
baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Dyspareunia Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.0</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">2% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.2 to -0.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dyspareunia at week 24. Change from 
baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Dyspareunia Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.8</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.1 to -0.5</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in dyspareunia at week 24. Change from 
baseline was analyzed using a mixed-effects repeated measures (MERM) 
analysis of covariance model which included fixed effects for treatment,
 time, treatment-by-time interaction, a random effect for patient, and 
terms for baseline value and the baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome14" id="outcome14"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">14.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Non-menstrual Pelvic Pain 
Component of the CPSSS During the Treatment Period &nbsp; [ Time Frame: 
Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Non-menstrual Pelvic Pain Component of the CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">The non-menstrual pelvic
 pain score was based on participant's response to the question "Have 
you had pelvic pain during the last 28 days?".</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Non-menstrual Pelvic 
Pain Component of the CPSSS During the Treatment Period&nbsp;           
             <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.3&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.2&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.1&nbsp;&nbsp;(0.11)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Non-menstrual Pelvic Pain Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.2</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.4 to -1.0</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in non-menstrual pelvic pain at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Non-menstrual Pelvic Pain Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.2</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.4 to -1.0</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in non-menstrual pelvic pain at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Non-menstrual Pelvic Pain Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.1</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.3 to -0.8</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      <p style="margin-top:0ex; margin-bottom:1ex;">Within-group analysis of change from baseline in non-menstrual pelvic pain at week 24.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome15" id="outcome15"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">15.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Pelvic Tenderness Component of 
the CPSSS During the Treatment Period &nbsp; [ Time Frame: Baseline and 
weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Pelvic Tenderness Component of the CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Pelvic tenderness was assessed by the investigator based on findings associated with a pelvic examination.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Pelvic Tenderness 
Component of the CPSSS During the Treatment Period&nbsp;                
        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;72&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-1.0&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Pelvic Tenderness Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.0</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.2 to -0.8</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic tenderness at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Pelvic Tenderness Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.0</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.1 to -0.8</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic tenderness at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Pelvic Tenderness Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.9</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.1 to -0.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic tenderness at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome16" id="outcome16"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">16.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Pelvic Induration Component of 
the CPSSS During the Treatment Period &nbsp; [ Time Frame: Baseline and 
weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Pelvic Induration Component of the CPSSS During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 CPSSS consists of 5 components that address dysmenorrhea, dyspareunia, 
non-menstrual pelvic pain, pelvic tenderness, and pelvic induration. 
Each component was scored on a scale of 0 to 3 (0 = absent, 1 = mild, 2 =
 moderate, and 3 = severe).</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Pelvic induration was assessed by the investigator based on findings associated with a pelvic examination.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Pelvic Induration 
Component of the CPSSS During the Treatment Period&nbsp;                
        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.4&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.5&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.5&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;72&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.6&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.7&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.08)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.9&nbsp;&nbsp;(0.09)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-0.8&nbsp;&nbsp;(0.10)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in Pelvic Induration Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.9</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.0 to -0.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic induration at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in Pelvic Induration Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.9</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.1 to -0.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic induration at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in Pelvic Induration Component of the CPSSS During the Treatment Period</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt;0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.8</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.9 to -0.6</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in pelvic induration at week 24. Change
 from baseline was analyzed using a mixed-effects repeated measures 
(MERM) analysis of covariance model which included fixed effects for 
treatment, time, treatment-by-time interaction, a random effect for 
patient, and terms for baseline value and the baseline-by-time 
interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome17" id="outcome17"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">17.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in in Monthly Peak Visual Analog 
Scale (VAS) for Pelvic Pain &nbsp; [ Time Frame: Baseline and weeks 4, 
8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in in Monthly Peak Visual Analog Scale (VAS) for Pelvic Pain</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 VAS for pelvic pain was used as an assessment of pain intensity. The 
VAS was a horizontal line on which the left extreme was labeled “no 
pain” and the right extreme was labeled “worst pain ever felt” scored on
 a scale from of 0 (no pain) to 100 (worst pain ever felt). Participants
 indicated the worst level of pain felt over a 24-hour period by 
‘‘ticking’’ the horizontal line on their e-Diary at approximately the 
same time each day. Monthly peak VAS for pelvic pain was defined as the 
maximum VAS pain score reported for an individual participant from the 
previous visit to the day of the current scheduled visit.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in in Monthly Peak Visual 
Analog Scale (VAS) for Pelvic Pain&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;84&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.2&nbsp;&nbsp;(2.97)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.4&nbsp;&nbsp;(2.96)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.4&nbsp;&nbsp;(2.98)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;78&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.3&nbsp;&nbsp;(3.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.1&nbsp;&nbsp;(3.02)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.1&nbsp;&nbsp;(3.08)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.3&nbsp;&nbsp;(3.14)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.7&nbsp;&nbsp;(3.09)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.9&nbsp;&nbsp;(3.20)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.1&nbsp;&nbsp;(3.24)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.8&nbsp;&nbsp;(3.19)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.8&nbsp;&nbsp;(3.38)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.0&nbsp;&nbsp;(3.40)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.9&nbsp;&nbsp;(3.23)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.0&nbsp;&nbsp;(3.51)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.3&nbsp;&nbsp;(3.51)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.9&nbsp;&nbsp;(3.31)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.8&nbsp;&nbsp;(3.65)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in in Monthly Peak Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-32.3</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-39.2 to -25.4</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in peak VAS for pelvic pain at week 24.
 Change from baseline was analyzed using a mixed-effects repeated 
measures (MERM) analysis of covariance model which included fixed 
effects for treatment, time, treatment-by-time interaction, a random 
effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in in Monthly Peak Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-32.9</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-39.4 to -26.4</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in peak VAS for pelvic pain at week 24.
 Change from baseline was analyzed using a mixed-effects repeated 
measures (MERM) analysis of covariance model which included fixed 
effects for treatment, time, treatment-by-time interaction, a random 
effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in in Monthly Peak Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-35.8</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-43.0 to -28.6</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in peak VAS for pelvic pain at week 24.
 Change from baseline was analyzed using a mixed-effects repeated 
measures (MERM) analysis of covariance model which included fixed 
effects for treatment, time, treatment-by-time interaction, a random 
effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome18" id="outcome18"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">18.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in in Monthly Mean Visual Analog 
Scale (VAS) for Pelvic Pain &nbsp; [ Time Frame: Baseline and weeks 4, 
8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in in Monthly Mean Visual Analog Scale (VAS) for Pelvic Pain</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 VAS for pelvic pain was used as an assessment of pain intensity. The 
VAS was a horizontal line on which the left extreme was labeled “no 
pain” and the right extreme was labeled “worst pain ever felt” scored on
 a scale from of 0 (no pain) to 100 (worst pain ever felt). Participants
 indicated the worst level of pain felt over a 24-hour period by 
‘‘ticking’’ the horizontal line on their e-Diary at approximately the 
same time each day. Monthly mean VAS for pelvic pain defined as the 
average of all VAS pain scores reported for an individual participant 
from the previous visit to the day of the current scheduled visit.</p>
  <p style="margin-top:0ex; margin-bottom:1ex;">Change from baseline was
 analyzed using a mixed-effects repeated measures (MERM) analysis of 
covariance model which included fixed effects for treatment, time, 
treatment-by-time interaction, a random effect for patient, and terms 
for baseline value and the baseline-by-time interaction.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in in Monthly Mean Visual 
Analog Scale (VAS) for Pelvic Pain&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;84&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.2&nbsp;&nbsp;(1.59)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-11.7&nbsp;&nbsp;(1.58)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.2&nbsp;&nbsp;(1.59)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;76&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;78&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.0&nbsp;&nbsp;(2.09)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.8&nbsp;&nbsp;(2.06)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.9&nbsp;&nbsp;(2.10)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.7&nbsp;&nbsp;(2.24)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.4&nbsp;&nbsp;(2.19)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.5&nbsp;&nbsp;(2.27)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.8&nbsp;&nbsp;(2.51)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.6&nbsp;&nbsp;(2.45)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.3&nbsp;&nbsp;(2.57)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.6&nbsp;&nbsp;(2.53)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.1&nbsp;&nbsp;(2.43)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.1&nbsp;&nbsp;(2.59)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.2&nbsp;&nbsp;(2.57)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.4&nbsp;&nbsp;(2.47)&nbsp; 
                                                                        
                             </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.9&nbsp;&nbsp;(2.64)&nbsp; 
                                                                        
                             </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline in in Monthly Mean Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-18.2</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-23.3 to -13.1</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in monthly mean VAS for pelvic pain at 
week 24. Change from baseline was analyzed using a mixed-effects 
repeated measures (MERM) analysis of covariance model which included 
fixed effects for treatment, time, treatment-by-time interaction, a 
random effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline in in Monthly Mean Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Elagolix 75 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-23.4</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-28.3 to -18.5</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in monthly mean VAS for pelvic pain at 
week 24. Change from baseline was analyzed using a mixed-effects 
repeated measures (MERM) analysis of covariance model which included 
fixed effects for treatment, time, treatment-by-time interaction, a 
random effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 3 for Change From Baseline in in Monthly Mean Visual Analog Scale (VAS) for Pelvic Pain</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">DMPA-SC</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Other</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">t-test, 2 sided</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.0001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least squares mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-17.9</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-23.1 to -12.7</td>
                            </tr>
                                                                                                                      
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Within-group 
analysis of change from baseline in peak VAS for pelvic pain at week 24.
 Change from baseline was analyzed using a mixed-effects repeated 
measures (MERM) analysis of covariance model which included fixed 
effects for treatment, time, treatment-by-time interaction, a random 
effect for patient, and terms for baseline value and the 
baseline-by-time interaction.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          P-value for 
test of null hypothesis that the treatment group least squares mean is 
equal to zero.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome19" id="outcome19"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">19.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in Endometriosis Health Profile–5 
(EHP-5) Pain Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12,
 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in Endometriosis Health Profile–5 (EHP-5) Pain Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), where 0 indicates the best health status and 100 
worst health status. A negative change from baseline score indicates 
improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in Endometriosis Health 
Profile–5 (EHP-5) Pain Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.7&nbsp;&nbsp;(2.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.9&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.7&nbsp;&nbsp;(2.5)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.0&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.0&nbsp;&nbsp;(2.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.3&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.2&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.4&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.4&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.9&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.9&nbsp;&nbsp;(2.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.8&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.3&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.8&nbsp;&nbsp;(2.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.3&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.9&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.5&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.9&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in Endometriosis Health Profile–5 (EHP-5) Pain Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome20" id="outcome20"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">20.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Control and Powerlessness 
Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 
24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Control and Powerlessness Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), where 0 indicates the best health status and 100 
worst health status. A negative change from baseline score indicates 
improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Control and Powerlessness Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.8&nbsp;&nbsp;(2.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.7&nbsp;&nbsp;(3.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.9&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.7&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.0&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.2&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.6&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.2&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.1&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-34.4&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.3&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.1&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.9&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.1&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-34.9&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.3&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.1&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.8&nbsp;&nbsp;(5.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Control and Powerlessness Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome21" id="outcome21"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">21.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Emotional Well-being Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Emotional Well-being Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), where 0 indicates the best health status and 100 
worst health status. A negative change from baseline score indicates 
improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Emotional Well-being Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-12.7&nbsp;&nbsp;(2.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-10.4&nbsp;&nbsp;(2.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-5.1&nbsp;&nbsp;(2.8)&nbsp;   
                                                                        
                           </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.6&nbsp;&nbsp;(2.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.0&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-13.4&nbsp;&nbsp;(2.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.0&nbsp;&nbsp;(3.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.9&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.6&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.1&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.7&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.9&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.8&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.8&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.4&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.1&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.8&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.5&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Emotional Well-being Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome22" id="outcome22"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">22.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Social Support Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Social Support Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), where 0 indicates the best health status and 100 
worst health status. A negative change from baseline score indicates 
improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Social Support Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.3&nbsp;&nbsp;(3.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.5&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.6&nbsp;&nbsp;(2.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.4&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.7&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.8&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-36.8&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-34.6&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.4&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-42.2&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.0&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.0&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-42.1&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-39.0&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-34.9&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-43.4&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-40.0&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.8&nbsp;&nbsp;(5.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Social Support Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome23" id="outcome23"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">23.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Self Image Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Self Image Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), where 0 indicates the best health status and 100 
worst health status. A negative change from baseline score indicates 
improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Self Image Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;81&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;82&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;83&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-11.1&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.1&nbsp;&nbsp;(2.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-11.1&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;74&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.6&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.7&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.5&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;67&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.1&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-22.6&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.3&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.3&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.7&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.9&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;68&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.8&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.1&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.3&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.7&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.9&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.5&nbsp;&nbsp;(4.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Self Image Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome24" id="outcome24"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">24.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Work Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Work Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), or Not Relevant (no score), where 0 indicates the 
best health status and 100 worst health status. A negative change from 
baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Work Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;73&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;75&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.5&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.9&nbsp;&nbsp;(2.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.0&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;64&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.2&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.8&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.8&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;62&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;66&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-21.8&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.2&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.4&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.6&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.6&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.6&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.1&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.5&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.4&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;51&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;58&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;44&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.0&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.7&nbsp;&nbsp;(3.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.8&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Work Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome25" id="outcome25"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">25.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Relationship With Children
 Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and
 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Relationship With Children Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), or Not Relevant (no score), where 0 indicates the 
best health status and 100 worst health status. A negative change from 
baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Relationship With Children Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;37&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.1&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.9&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.1&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;36&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-19.9&nbsp;&nbsp;(4.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.8&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.4&nbsp;&nbsp;(3.9)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;37&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.0&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.7&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.6&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;31&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;32&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;30&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-24.2&nbsp;&nbsp;(4.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.6&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.8&nbsp;&nbsp;(5.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;27&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;28&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;28&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.8&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.0&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.6&nbsp;&nbsp;(5.7)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;26&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;29&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;26&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.8&nbsp;&nbsp;(4.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.3&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.7&nbsp;&nbsp;(6.0)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Relationship With Children Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome26" id="outcome26"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">26.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Intercourse Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Intercourse Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), or Not Relevant (no score), where 0 indicates the 
best health status and 100 worst health status. A negative change from 
baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Intercourse Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.3&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.5&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.4&nbsp;&nbsp;(3.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;62&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.8&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.2&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.5&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;61&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;56&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.1&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.5&nbsp;&nbsp;(4.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-20.5&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;54&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;43&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.7&nbsp;&nbsp;(4.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.2&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-23.3&nbsp;&nbsp;(5.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;41&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.7&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-31.7&nbsp;&nbsp;(4.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-25.0&nbsp;&nbsp;(5.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;39&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.3&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-33.9&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.5&nbsp;&nbsp;(5.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Intercourse Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome27" id="outcome27"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">27.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Medical Profession Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Medical Profession Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), or Not Relevant (no score), where 0 indicates the 
best health status and 100 worst health status. A negative change from 
baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Medical Profession Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;70&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;69&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;71&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-13.2&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-9.1&nbsp;&nbsp;(2.6)&nbsp;   
                                                                        
                           </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-12.0&nbsp;&nbsp;(2.6)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;62&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;63&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;65&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.3&nbsp;&nbsp;(3.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.7&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-13.5&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.7&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.2&nbsp;&nbsp;(3.7)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.0&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;59&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;49&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.9&nbsp;&nbsp;(3.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.4&nbsp;&nbsp;(3.4)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-17.9&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;60&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.2&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.6&nbsp;&nbsp;(3.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-15.6&nbsp;&nbsp;(3.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;57&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-18.8&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-14.0&nbsp;&nbsp;(3.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-16.0&nbsp;&nbsp;(4.1)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Medical Profession Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome28" id="outcome28"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">28.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline in EHP-5 Treatment Dimension &nbsp; [ Time Frame: Baseline and weeks 4, 8, 12, 16, 20, and 24 ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline in EHP-5 Treatment Dimension</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          <p style="margin-top:0ex; margin-bottom:1ex;">The
 EHP-5 is an instrument to measure health-related quality of life in 
women with endometriosis. The EHP-5 consists of two parts:</p>
  <ul style="margin-top:1ex; margin-bottom:1ex;">
    <li style="margin-top:0.7ex;">A core questionnaire consisting of 
five questions that measure the areas of pain, control and 
powerlessness, emotional well-being, social support, and self-image</li>
    <li style="margin-top:0.7ex;">A supplemental questionnaire 
consisting of six additional questions, five of which were recorded in 
this study: work, relationship with children, sexual intercourse, 
feelings about the medical profession and treatment.</li>
  </ul>
  <p style="margin-top:0ex; margin-bottom:1ex;">Each question was scored
 on a five point scale (Never = 0, Rarely = 25, Sometimes = 50, Often = 
75, Always = 100), or Not Relevant (no score), where 0 indicates the 
best health status and 100 worst health status. A negative change from 
baseline score indicates improvement in quality of life.</p>
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline and weeks 4, 8, 12, 16, 20, and 24 &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat) with available data at each time point.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline in EHP-5 Treatment Dimension&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 4&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;52&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;53&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;55&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 4&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-27.4&nbsp;&nbsp;(5.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-30.2&nbsp;&nbsp;(4.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-26.8&nbsp;&nbsp;(4.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 8&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;48&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;50&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 8&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-32.8&nbsp;&nbsp;(6.3)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.0&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-29.8&nbsp;&nbsp;(4.8)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 12&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;45&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 12&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.0&nbsp;&nbsp;(6.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-37.2&nbsp;&nbsp;(5.5)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.0&nbsp;&nbsp;(5.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 16&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;38&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;47&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 16&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-36.8&nbsp;&nbsp;(6.9)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-38.3&nbsp;&nbsp;(4.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.6&nbsp;&nbsp;(6.4)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 20&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;35&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;46&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 20&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.7&nbsp;&nbsp;(6.6)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-34.8&nbsp;&nbsp;(5.2)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.6&nbsp;&nbsp;(6.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                        <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Week 24&nbsp;                                                  </td>
                                                                              <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                      <td class="br pale_outcome_color">&nbsp;</td>
                                                                        </tr>
                                                                        <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Participants Analyzed&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;33&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;42&nbsp;                                                          
        </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                      
&nbsp;32&nbsp;                                                          
        </td>
                                                                                    </tr>
                                                  <tr>
                            <td class="header3 br bold_outcome_color" style="padding:0px 5px 2px 4em;">
                              Week 24&nbsp;                                                          </td>
                                                                                          <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-35.6&nbsp;&nbsp;(7.1)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-39.3&nbsp;&nbsp;(5.0)&nbsp;  
                                                                        
                            </td>
                                                              <td class="header3 br pale_outcome_color" style="padding:0px 5px 2px 5px;text-align:center;">
                                                                        
                                    &nbsp;-28.9&nbsp;&nbsp;(7.3)&nbsp;  
                                                                        
                            </td>
                                                                                    </tr>
                                                                                                                  </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Change From Baseline in EHP-5 Treatment Dimension</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome29" id="outcome29"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">29.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Participants Using Analgesics During the Treatment Phase &nbsp; [ Time Frame: 24 weeks ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Participants Using Analgesics During the Treatment Phase</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Analgesic use was collected as
 part of concomitant medications on a case report form that was 
administered at each scheduled visit.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">24 weeks &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          All randomized participants 
who received at least one oral dose of study drug, an initial 
subcutaneous injection, and either reported at least 7 e-diary VAS 
values or provided an assessment of either dysmenorrhea or non-menstrual
 pelvic pain at week 4 or later during the treatment phase 
(intent-to-treat).
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 150 mg orally 
once a day (QD) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 75 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received elagolix 75 mg orally 
twice a day (BID) for 24 weeks and placebo to DMPA-SC by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">DMPA-SC</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Participants received placebo to elagolix 
orally once a day for 24 weeks and DMPA-SC 104 mg by subcutaneous 
injection at weeks 1 and 12.
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 75 mg BID&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;DMPA-SC&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;84&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;83&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Participants Using Analgesics During the Treatment Phase&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Antiinflammatory/Antirheumatics, Non-Steroids&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;65.5&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;64.3&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;68.7&nbsp;                                                        
  </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Opioids&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;23.8&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;25.0&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;33.7&nbsp;                                                        
  </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Other Analgesics and Antipyretics&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;45.2&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;46.4&nbsp;                                                        
  </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;34.9&nbsp;                                                        
  </td>
                                                                        </tr>
                                                                                          </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Percentage of Participants Using Analgesics During the Treatment Phase</span>
                <br>

                            <br>
              <br>
                              </div>
          </div>
</div>
  
<!-- adverse events section -->
<br>
<div class="indent1">

  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Serious Adverse Events</span><br>
  <a name="evnt" id="evnt"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show serious adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X301256#evnt">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Serious Adverse Events
      </a>
    </div>
      </div>

  <br>
  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Other Adverse Events</span>
  <a name="othr" id="othr"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show other adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X401256#othr">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Other Adverse Events
      </a>
    </div>
      </div>
</div>
  
<!-- limitations and caveats section -->
<div class="indent1">

  <br>
  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Limitations and Caveats</span>

  <a name="limit" id="limit"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide Limitations and Caveats" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X0126#limit">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Limitations and Caveats
      </a>
    </div>

    <br>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_more_info_color" style="text-align:left;">
          Limitations of the study, such as early termination leading to small numbers of participants
          analyzed and technical problems with measurement leading to unreliable or uninterpretable data
        </th>
      </tr>
      <tr>
        <td class="body3 pale_more_info_color" style="vertical-align:top;">
                      No text entered.
                  </td>
      </tr>
    </tbody></table>

    </div>
</div>
  
<!-- more results info section -->
<br>
<div class="indent1">

  <br>
  <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; More Information</span>
  <a name="more" id="more"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide more information" href="https://clinicaltrials.gov/ct2/show/results/NCT00437658?sect=X0125#more">
        <img style="float:left" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide More Information
      </a>
    </div>

    <br>
    <div class="body3">

          <span class="header3">Certain Agreements: &nbsp; </span>
      <table class="layout_table" style="margin-top:0.5ex; border:1px solid #ccc;" width="100%" cellspacing="0" cellpadding="5">
              <tbody><tr>
          <td class="body3 pale_more_info_color">
                          Principal Investigators are <b>NOT</b> employed by the organization sponsoring the study.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
                          There <b>IS</b> an agreement between Principal Investigators and the Sponsor (or its agents) that restricts
              the PI's rights to discuss or publish trial results after the trial is completed.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
          The agreement is:<br>

          <table class="layout_table" cellspacing="0" cellpadding="5" border="0">
            <tbody><tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>less than or equal to 60 days</b>.
                The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>more than 60 days but less than
                or equal to 180 days</b>. The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr class="banner_color" style="vertical-align:middle;">
              <td class="header1" nowrap="nowrap">
                <img src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/check.gif" alt="checked">              </td>
              <td class="body3">
                Other disclosure agreement that restricts the right of 
the PI to discuss or publish trial results after the trial is completed.
                                  <br>
                  <br>
                  <span class="header3">Restriction Description:</span> 
&nbsp;
                                      AbbVie requests that any 
investigator or institution that plans on presenting/publishing results 
disclosure, provide written notification of their request 60 days prior 
to their presentation/publication. AbbVie requests that no 
presentation/publication will be instituted until 12 months after a 
study is completed, or after the first presentation/publication 
whichever occurs first. A delay may be proposed of a 
presentation/publication if AbbVie needs to secure patent or proprietary
 protection.
                                                </td>
            </tr>
          </tbody></table>
          </td>
        </tr>
            </tbody></table>
    
    <br>
          <br>
            <span class="header3">Results Point of Contact: &nbsp; </span>
      <div class="indent2" style="margin-top:1ex">
        Name/Title: Global Medical Services<br>
                  Organization: AbbVie<br>
                          phone: 800-633-9110<br>
                      </div>
      <br>
    
    <br>

    
    
    
    <br>
    <table class="layout_table" cellspacing="0" cellpadding="0" border="0">
            <tbody><tr style="vertical-align:top;">
        <td nowrap="nowrap">Responsible Party:</td>
        <td style="padding-left:1em">AbbVie</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">ClinicalTrials.gov Identifier:</td>
        <td style="padding-left:1em">
          <a title="Current version of study NCT00437658 on ClinicalTrials.gov" href="https://clinicaltrials.gov/show/NCT00437658">NCT00437658</a> &nbsp; &nbsp;
          <a href="https://clinicaltrials.gov/ct2/archive/NCT00437658" title="Historical versions of study NCT00437658 on ClinicalTrials.gov Archive Site" onclick="openNewWindow('/ct2/archive/NCT00437658'); return false;">History of Changes</a>
        </td>
      </tr>
                  <tr style="vertical-align:top;">
        <td headers="colTitle" nowrap="nowrap">Other Study ID Numbers:</td>
        <td headers="colData" style="padding-left:1em">
                                    NBI-56418-0603 <br>
                              </td>
      </tr>
      
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Submitted:</td>
        <td style="padding-left:1em">February 16, 2007</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Posted:</td>
        <td style="padding-left:1em">February 21, 2007</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Submitted:</td>
        <td style="padding-left:1em">August 9, 2018</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Posted:</td>
        <td style="padding-left:1em">October 12, 2018</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">Last Update Posted:</td>
        <td style="padding-left:1em">October 12, 2018
        </td>
      </tr>

    </tbody></table>

    </div>
    </div>
</div>

<br>
<br>
<br>
</div>
<div id="to-top"><a href="#wrapper">To Top</a></div>
</div>


	<div style="clear:both;"></div>
</div> 

<div>       <div id="for-footer">
        <ul class="horz-list">
            <li style="border-left:0;"><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

</div>  
<div id="footer-menu">
    <ul class="horz-list" style="padding-bottom:1.5ex;">
		<li><a href="https://clinicaltrials.gov/ct2/home" style="white-space:nowrap">Home</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/resources/rss" style="white-space:nowrap">RSS Feeds</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/sitemap" style="white-space:nowrap">Site Map</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions" style="white-space:nowrap">Terms and Conditions</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer" style="white-space:nowrap">Disclaimer</a></li>
		<li><a href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00437658%3Fsect%3DX01256" style="white-space:nowrap" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00437658%3Fsect%3DX01256'); return false">Customer Support</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="horz-list">
		<li><a title="NLM copyright information - opens new window" href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false">Copyright</a></li>
		<li><a title="NLM privacy policy - opens new window" href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false">Privacy</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
		<li><a title="NLM viewers and players - opens new window" href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false">Viewers and Players</a></li>
		<li><a title="NIH Freedom of Information Act office - opens new window" href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false">Freedom of Information Act</a></li>
		<li class="last-item"><a title="USA.gov - opens new window" href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false">USA.gov</a></li>
	</ul>
    <ul class="horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window" href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false">U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window" href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false">U.S. National Institutes of Health</a></li>
       <li class="last-item"><a title="U.S. Department of Health and Human Services - opens new window" href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false">
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

<script type="text/javascript">__ncbi_sg_gaMode="clinicaltrials"</script>
<script type="text/javascript" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/instrumentNCBIBaseJS.js"></script><script async="1" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/analytics.js"></script><noscript></noscript>
<script type="text/javascript" src="Elagolix%20Versus%20Subcutaneous%20Depot%20Medroxyprogesterone%20Acetate%20for%20the%20Treatment%20of%20Endometriosis%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/main-glossary.js"></script><noscript></noscript>



<ul class="print-log"><li></li></ul></body></html>